(Q33951598)

English

Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History Study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

anti-retroviral agent

0 references

0 references

object named as

Brian K Agan

12

0 references

Vincent C Marconi

object named as

Vincent C Marconi

1

0 references

Anuradha Ganesan

6

object named as

Anuradha Ganesan

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

3

object named as

Amy C Weintrob

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Nancy F Crum-Cianflone

8

object named as

Nancy Crum-Cianflone

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Jason F. Okulicz

7

object named as

Jason F Okulicz

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Greg A Grandits

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Helen Chun

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Michael L Landrum

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Robert J O'Connell

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Alan Lifson

10

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Glenn W Wortmann

11

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Infectious Disease Clinical Research Program HIV Working Group (IDCRP)

13

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

27 May 2010

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

AIDS Research and Therapy

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

https://scigraph.springernature.com/pub.10.1186/1742-6405-7-14

0 references

Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894737

5 July 2018

Food insecurity is associated with incomplete HIV RNA suppression among homeless and marginally housed HIV-infected individuals in San Francisco

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894737

5 July 2018

Estimation of HIV incidence in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894737

5 July 2018

Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894737

5 July 2018

Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894737

5 July 2018

Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894737

5 July 2018

CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894737

5 July 2018

Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894737

5 July 2018

Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894737

5 July 2018

HIV incidence trends among white and african-american active duty United States Army personnel (1986-2003).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894737

5 July 2018

Temporal changes in the physical fitness of US Army recruits

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894737

5 July 2018

Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894737

5 July 2018

Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894737

5 July 2018

Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894737

5 July 2018

Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894737

5 July 2018

Progressive resistive exercise interventions for adults living with HIV/AIDS

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894737

5 July 2018

Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894737

5 July 2018

HIV treatment adherence and unprotected sex practices in people receiving antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894737

5 July 2018

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894737

5 July 2018

Response to highly active antiretroviral therapy according to duration of HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894737

5 July 2018

The fitness training unit in U.S. Army basic combat training: physical fitness, training outcomes, and injuries.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894737

5 July 2018

Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AAC

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894737

5 July 2018

Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy

1 reference

https://api.crossref.org/works/10.1186%2F1742-6405-7-14

21 January 2018

Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study.

1 reference

https://api.crossref.org/works/10.1186%2F1742-6405-7-14

21 January 2018

Diverse HIV-1 subtypes and clinical, laboratory and behavioral factors in a recently infected US military cohort

1 reference

https://api.crossref.org/works/10.1186%2F1742-6405-7-14

21 January 2018

Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease.

1 reference

https://api.crossref.org/works/10.1186%2F1742-6405-7-14

21 January 2018

Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor.

1 reference

https://api.crossref.org/works/10.1186%2F1742-6405-7-14

21 January 2018

Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.

1 reference

https://api.crossref.org/works/10.1186%2F1742-6405-7-14

21 January 2018

Superior virological response to boosted protease inhibitor-based highly active antiretroviral therapy in an observational treatment programme.

1 reference

https://api.crossref.org/works/10.1186%2F1742-6405-7-14

21 January 2018

Optimizing resource allocation in United States AIDS drug assistance programs.

1 reference

https://api.crossref.org/works/10.1186%2F1742-6405-7-14

21 January 2018

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

1 reference

https://api.crossref.org/works/10.1186%2F1742-6405-7-14

21 January 2018

Impact of neighborhood-level socioeconomic status on HIV disease progression in a universal health care setting.

1 reference

https://api.crossref.org/works/10.1186%2F1742-6405-7-14

21 January 2018

Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996.

1 reference

https://api.crossref.org/works/10.1186%2F1742-6405-7-14

21 January 2018

The influence of psychosocial characteristics and race/ethnicity on the use, duration, and success of antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1186%2F1742-6405-7-14

21 January 2018

Effectiveness of highly-active antiretroviral therapy by race/ethnicity

1 reference

https://api.crossref.org/works/10.1186%2F1742-6405-7-14

21 January 2018

Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1186%2F1742-6405-7-14

21 January 2018

Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.

1 reference

https://api.crossref.org/works/10.1186%2F1742-6405-7-14

21 January 2018

CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1186%2F1742-6405-7-14

21 January 2018

HIV treatment beliefs and sexual transmission risk behaviors among HIV positive men and women

1 reference

https://api.crossref.org/works/10.1186%2F1742-6405-7-14

21 January 2018

Reducing medical attrition: the role of the Accession Medical Standards Analysis and Research Activity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894737

29 October 2018

Directly observed therapy programmes for anti-retroviral treatment amongst injection drug users in Vancouver: Access, adherence and outcomes

1 reference

https://api.crossref.org/works/10.1186%2F1742-6405-7-14

21 January 2018

Virologic Response Differences Between African Americans and European Americans Initiating Highly Active Antiretroviral Therapy With Equal Access to Care

1 reference

https://api.crossref.org/works/10.1186%2F1742-6405-7-14

21 January 2018

Increasing Age at HIV Seroconversion From 18 to 40 Years Is Associated With Favorable Virologic and Immunologic Responses to HAART

1 reference

https://api.crossref.org/works/10.1186%2F1742-6405-7-14

21 January 2018

Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to <500 Cells/ L in HIV Type 1--Infected Individuals Receiving Potent Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1186%2F1742-6405-7-14

21 January 2018

Predictors of Virological Success and Ensuing Failure in HIV-Positive Patients Starting Highly Active Antiretroviral Therapy in Europe

1 reference

https://api.crossref.org/works/10.1186%2F1742-6405-7-14

21 January 2018

Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20507622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load

1 reference

https://pubmed.ncbi.nlm.nih.gov/20507622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen

1 reference

https://pubmed.ncbi.nlm.nih.gov/20507622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

When to begin highly active antiretroviral therapy? Evidence supporting initiation of therapy at CD4+ lymphocyte counts <350 cells/microL

1 reference

https://pubmed.ncbi.nlm.nih.gov/20507622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence

1 reference

https://pubmed.ncbi.nlm.nih.gov/20507622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/20507622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of plasma HIV RNA among highly active antiretroviral therapy users

1 reference

https://pubmed.ncbi.nlm.nih.gov/20507622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Virologic and immunologic response to highly active antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20507622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort

1 reference

https://pubmed.ncbi.nlm.nih.gov/20507622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determinants of progression to AIDS or death after HIV diagnosis, United States, 1996 to 2001

1 reference

https://pubmed.ncbi.nlm.nih.gov/20507622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The association of antidepressant medication adherence with employee disability absences

1 reference

https://pubmed.ncbi.nlm.nih.gov/20507622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART

1 reference

https://pubmed.ncbi.nlm.nih.gov/20507622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

From the Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/20507622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: a multicenter, cross-sectional study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20507622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1742-6405-7-14

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33951598&oldid=1677332980"